CSIMarket
 


Pluristem Therapeutics Inc  (PSTI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Pluristem Therapeutics Inc's Quick Ratio

PSTI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




PSTI Quick Ratio (Dec 31 2019)
II. Quarter
(Sep 30 2019)
I. Quarter
(Jun 30 2019)
IV. Quarter
(Mar 31 2019)
III. Quarter
(Dec 31 2018)
II. Quarter
Y / Y Current Liabilities Change -16.69 % -7.02 % -4.56 % 5.64 % 24.79 %
Y / Y Cash & cash equivalent Change 6.54 % -15.02 % -20.24 % -67.01 % -21.4 %
Quick Ratio MRQ 2.76 2.78 2.99 1.36 2.16
Overall Ranking # # # # #
Seq. Current Liabilities Change -12.39 % -15.68 % -1.08 % 14 % -2.22 %
Seq. Cash & cash equivalent Change -12.89 % -21.65 % 117.06 % -28.08 % -30.52 %



Quick Ratio second quarter 2019 Comment
Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 2.76 below company average Quick Ratio.

Within Biotechnology & Drugs industry 18 other companies have achieved higher Quick Ratio than Pluristem Therapeutics Inc in second quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are PSTI Segments?
See Quick Ratio PSTI on the trailing twelve month basis
Quick Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 19
Healthcare Sector # 51
Overall Market # 165


Quick Ratio Statistics
High Average Low
8.96 4.56 1.36
(Sep 30 2012)   (Mar 31 2019)




Financial Statements
Pluristem Therapeutics Inc's Current Liabilities $ 6 Millions Visit PSTI's Balance sheet
Pluristem Therapeutics Inc's Cash & cash equivalent $ 17 Millions Visit PSTI's Balance sheet
Source of PSTI's Sales Visit PSTI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingDec 31 2019, within Biotechnology & Drugs Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Proteostasis Therapeutics Inc   7.59 $ 69.467  Millions$ 9.147  Millions
Fulgent Genetics Inc   7.59 $ 28.269  Millions$ 3.723  Millions
Urogen Pharma Ltd   7.55 $ 147.077  Millions$ 19.482  Millions
Xenetic Biosciences Inc   7.33 $ 10.368  Millions$ 1.415  Millions
Unity Biotechnology Inc   7.09 $ 121.981  Millions$ 17.216  Millions
Atara Biotherapeutics Inc   7.05 $ 259.109  Millions$ 36.743  Millions
Casi Pharmaceuticals Inc   6.83 $ 54.246  Millions$ 7.947  Millions
Vir Biotechnology Inc   6.58 $ 389.617  Millions$ 59.206  Millions
Gritstone Oncology Inc   6.55 $ 127.776  Millions$ 19.500  Millions
Merus N v   6.52 $ 239.765  Millions$ 36.787  Millions
Compugen Ltd  6.43 $ 43.879  Millions$ 6.819  Millions
Genocea Biosciences, Inc.  6.39 $ 40.127  Millions$ 6.281  Millions
Cannabics Pharmaceuticals Inc.  6.38 $ 2.810  Millions$ 0.441  Millions
Akers Biosciences Inc   6.33 $ 9.682  Millions$ 1.530  Millions
Cohbar Inc   6.16 $ 12.564  Millions$ 2.039  Millions
Fennec Pharmaceuticals Inc.  6.01 $ 13.650  Millions$ 2.271  Millions
Lineage Cell Therapeutics Inc   5.83 $ 30.716  Millions$ 5.271  Millions
Eyenovia Inc   5.81 $ 14.270  Millions$ 2.458  Millions
Eiger Biopharmaceuticals Inc   5.79 $ 94.994  Millions$ 16.415  Millions
Pulse Biosciences Inc   5.70 $ 25.398  Millions$ 4.459  Millions
Celldex Therapeutics Inc   5.53 $ 64.383  Millions$ 11.643  Millions
Opiant Pharmaceuticals Inc   5.52 $ 30.980  Millions$ 5.610  Millions
Surface Oncology Inc   5.46 $ 105.161  Millions$ 19.274  Millions
Cellectis S a   5.44 $ 340.522  Millions$ 62.604  Millions
Quotient Ltd  5.32 $ 138.035  Millions$ 25.930  Millions
Sangamo Therapeutics Inc   5.19 $ 362.474  Millions$ 69.872  Millions
Halozyme Therapeutics Inc   5.16 $ 421.262  Millions$ 81.625  Millions
Cue Biopharma Inc   5.10 $ 59.410  Millions$ 11.655  Millions
Anavex Life Sciences Corp.  5.03 $ 27.458  Millions$ 5.464  Millions
Cellect Biotechnology Ltd   4.98 $ 5.239  Millions$ 1.052  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RM's Profile

Stock Price

RM's Financials

Business Description

Fundamentals

Charts & Quotes

RM's News

Suppliers

RM's Competitors

Customers & Markets

Economic Indicators

RM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071